vs
Fortune Brands Innovations, Inc.（FBIN）与Idexx Laboratories（IDXX）财务数据对比。点击上方公司名可切换其他公司
Idexx Laboratories的季度营收约是Fortune Brands Innovations, Inc.的1.0倍（$1.1B vs $1.1B），Idexx Laboratories净利率更高（22.8% vs 7.1%，领先15.7%），Idexx Laboratories同比增速更快（14.3% vs -2.4%），Idexx Laboratories自由现金流更多（$326.3M vs $183.7M），过去两年Idexx Laboratories的营收复合增速更高（6.4% vs -1.5%）
Fortune Brands Innovations是美国家居及安防产品生产商，总部位于伊利诺伊州迪尔菲尔德，位列财富500强及标普400指数。旗下拥有摩恩、House of Rohl、玛斯特锁等知名品牌，业务覆盖厨卫、户外用品、安防、橱柜制造等领域，2021年底全球员工约2.8万人。
IDEXX Laboratories是1983年成立的美国跨国企业，主营伴侣动物诊疗、畜禽养殖、水质检测、乳制品领域相关产品与服务的研发、生产及分销，总部位于缅因州韦斯特布鲁克，欧洲、中东及非洲地区分部设于荷兰霍夫多普。
FBIN vs IDXX — 直观对比
营收规模更大
IDXX
是对方的1.0倍
$1.1B
营收增速更快
IDXX
高出16.7%
-2.4%
净利率更高
IDXX
高出15.7%
7.1%
自由现金流更多
IDXX
多$142.6M
$183.7M
两年增速更快
IDXX
近两年复合增速
-1.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.1B |
| 净利润 | $76.3M | $248.2M |
| 毛利率 | 43.8% | 60.3% |
| 营业利润率 | 11.3% | 28.9% |
| 净利率 | 7.1% | 22.8% |
| 营收同比 | -2.4% | 14.3% |
| 净利润同比 | -27.3% | 14.8% |
| 每股收益（稀释后） | $0.63 | $3.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FBINIDXX
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.0B | $998.4M | ||
| Q4 24 | $1.1B | $954.3M | ||
| Q3 24 | $1.2B | $975.5M | ||
| Q2 24 | $1.2B | $1.0B | ||
| Q1 24 | $1.1B | $964.1M |
净利润FBINIDXX
| Q4 25 | $76.3M | $248.2M | ||
| Q3 25 | $70.8M | $274.6M | ||
| Q2 25 | $100.3M | $294.0M | ||
| Q1 25 | $51.4M | $242.7M | ||
| Q4 24 | $105.0M | $216.1M | ||
| Q3 24 | $136.6M | $232.8M | ||
| Q2 24 | $133.9M | $203.3M | ||
| Q1 24 | $96.4M | $235.6M |
毛利率FBINIDXX
| Q4 25 | 43.8% | 60.3% | ||
| Q3 25 | 45.2% | 61.8% | ||
| Q2 25 | 45.1% | 62.6% | ||
| Q1 25 | 44.0% | 62.4% | ||
| Q4 24 | 46.0% | 59.8% | ||
| Q3 24 | 45.9% | 61.1% | ||
| Q2 24 | 43.6% | 61.7% | ||
| Q1 24 | 43.9% | 61.5% |
营业利润率FBINIDXX
| Q4 25 | 11.3% | 28.9% | ||
| Q3 25 | 11.0% | 32.1% | ||
| Q2 25 | 14.3% | 33.6% | ||
| Q1 25 | 9.4% | 31.7% | ||
| Q4 24 | 16.1% | 27.4% | ||
| Q3 24 | 17.8% | 31.2% | ||
| Q2 24 | 16.1% | 26.3% | ||
| Q1 24 | 14.0% | 31.0% |
净利率FBINIDXX
| Q4 25 | 7.1% | 22.8% | ||
| Q3 25 | 6.2% | 24.8% | ||
| Q2 25 | 8.3% | 26.5% | ||
| Q1 25 | 5.0% | 24.3% | ||
| Q4 24 | 9.5% | 22.7% | ||
| Q3 24 | 11.8% | 23.9% | ||
| Q2 24 | 10.8% | 20.3% | ||
| Q1 24 | 8.7% | 24.4% |
每股收益（稀释后）FBINIDXX
| Q4 25 | $0.63 | $3.09 | ||
| Q3 25 | $0.59 | $3.40 | ||
| Q2 25 | $0.83 | $3.63 | ||
| Q1 25 | $0.42 | $2.96 | ||
| Q4 24 | $0.84 | $2.62 | ||
| Q3 24 | $1.09 | $2.80 | ||
| Q2 24 | $1.06 | $2.44 | ||
| Q1 24 | $0.76 | $2.81 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $264.0M | $180.1M |
| 总债务越低越好 | $2.5B | $450.0M |
| 股东权益账面价值 | $2.4B | $1.6B |
| 总资产 | $6.5B | $3.4B |
| 负债/权益比越低杠杆越低 | 1.07× | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资FBINIDXX
| Q4 25 | $264.0M | $180.1M | ||
| Q3 25 | $223.9M | $208.2M | ||
| Q2 25 | $234.7M | $164.6M | ||
| Q1 25 | $340.0M | $164.0M | ||
| Q4 24 | $381.1M | $288.3M | ||
| Q3 24 | $344.8M | $308.6M | ||
| Q2 24 | $352.6M | $401.6M | ||
| Q1 24 | $359.7M | $397.4M |
总债务FBINIDXX
| Q4 25 | $2.5B | $450.0M | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $2.2B | — | ||
| Q1 25 | $2.7B | — | ||
| Q4 24 | $2.7B | $617.8M | ||
| Q3 24 | $2.7B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
股东权益FBINIDXX
| Q4 25 | $2.4B | $1.6B | ||
| Q3 25 | $2.4B | $1.6B | ||
| Q2 25 | $2.3B | $1.5B | ||
| Q1 25 | $2.3B | $1.4B | ||
| Q4 24 | $2.4B | $1.6B | ||
| Q3 24 | $2.4B | $1.6B | ||
| Q2 24 | $2.3B | $1.6B | ||
| Q1 24 | $2.3B | $1.6B |
总资产FBINIDXX
| Q4 25 | $6.5B | $3.4B | ||
| Q3 25 | $6.5B | $3.4B | ||
| Q2 25 | $6.6B | $3.3B | ||
| Q1 25 | $6.6B | $3.2B | ||
| Q4 24 | $6.6B | $3.3B | ||
| Q3 24 | $6.6B | $3.4B | ||
| Q2 24 | $6.7B | $3.4B | ||
| Q1 24 | $6.8B | $3.4B |
负债/权益比FBINIDXX
| Q4 25 | 1.07× | 0.28× | ||
| Q3 25 | 0.91× | — | ||
| Q2 25 | 0.93× | — | ||
| Q1 25 | 1.16× | — | ||
| Q4 24 | 1.10× | 0.39× | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.15× | — | ||
| Q1 24 | 1.17× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $208.2M | $355.8M |
| 自由现金流经营现金流 - 资本支出 | $183.7M | $326.3M |
| 自由现金流率自由现金流/营收 | 17.0% | 29.9% |
| 资本支出强度资本支出/营收 | 2.3% | 2.7% |
| 现金转化率经营现金流/净利润 | 2.73× | 1.43× |
| 过去12个月自由现金流最近4个季度 | $366.8M | $1.1B |
8季度趋势，按日历期对齐
经营现金流FBINIDXX
| Q4 25 | $208.2M | $355.8M | ||
| Q3 25 | $204.4M | $402.3M | ||
| Q2 25 | $149.4M | $185.7M | ||
| Q1 25 | $-83.4M | $238.0M | ||
| Q4 24 | $272.3M | $262.0M | ||
| Q3 24 | $205.3M | $220.1M | ||
| Q2 24 | $261.5M | $248.3M | ||
| Q1 24 | $-71.3M | $198.6M |
自由现金流FBINIDXX
| Q4 25 | $183.7M | $326.3M | ||
| Q3 25 | $177.0M | $371.2M | ||
| Q2 25 | $118.7M | $151.6M | ||
| Q1 25 | $-112.6M | $207.9M | ||
| Q4 24 | $212.1M | $232.8M | ||
| Q3 24 | $175.6M | $192.0M | ||
| Q2 24 | $222.7M | $215.0M | ||
| Q1 24 | $-135.9M | $168.3M |
自由现金流率FBINIDXX
| Q4 25 | 17.0% | 29.9% | ||
| Q3 25 | 15.4% | 33.6% | ||
| Q2 25 | 9.9% | 13.7% | ||
| Q1 25 | -10.9% | 20.8% | ||
| Q4 24 | 19.2% | 24.4% | ||
| Q3 24 | 15.2% | 19.7% | ||
| Q2 24 | 18.0% | 21.4% | ||
| Q1 24 | -12.2% | 17.5% |
资本支出强度FBINIDXX
| Q4 25 | 2.3% | 2.7% | ||
| Q3 25 | 2.4% | 2.8% | ||
| Q2 25 | 2.6% | 3.1% | ||
| Q1 25 | 2.8% | 3.0% | ||
| Q4 24 | 5.5% | 3.1% | ||
| Q3 24 | 2.6% | 2.9% | ||
| Q2 24 | 3.1% | 3.3% | ||
| Q1 24 | 5.8% | 3.1% |
现金转化率FBINIDXX
| Q4 25 | 2.73× | 1.43× | ||
| Q3 25 | 2.89× | 1.47× | ||
| Q2 25 | 1.49× | 0.63× | ||
| Q1 25 | -1.62× | 0.98× | ||
| Q4 24 | 2.59× | 1.21× | ||
| Q3 24 | 1.50× | 0.95× | ||
| Q2 24 | 1.95× | 1.22× | ||
| Q1 24 | -0.74× | 0.84× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FBIN
| Wholesale Retail Trade | $526.7M | 49% |
| Home Center Retailer | $257.1M | 24% |
| Security Segment | $165.8M | 15% |
| Other Retailer | $118.2M | 11% |
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |
